PROCEPT BioRobotics trades at 2.9x forward EV/2026E revenue, a deep discount to peers, despite 27-33% guided revenue growth. Learn why PRCT stock is a buy.

SAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025.

AngioDynamics, Inc. ( ANGO) Q3 2026 Earnings Call April 2, 2026 8:00 AM EDT Good morning, and welcome to the AngioDynamics Fiscal Year 2026 Third Quarter Earnings Call. [Operator Instructions] As a ...

Many people dream of solid jobs with good pay, yet years of school (and mountains of debt) often stand in the way. Careers with short training paths change that picture entirely. You can enter fields ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings inline with expectations. Reported EPS is $-2.475 EPS, expectations were ...

Recently, a reader gave me the idea to search for and make a list of work at home jobs that offer sign-on bonuses. I tho ...

Inspire Medical Systems INSP is well-positioned for solid growth over the next few quarters as it navigates a significant ...

An Antwerp court supports India's extradition request for fugitive Mehul Choksi, dismissing his abduction claims and asylum ...

For over 5 years, Arthur has been professionally covering video games, writing guides and walkthroughs. His passion for video games began at age 10 in 2010 when he first played Gothic, an immersive ...